FDA Authorizes Moderna and Pfizer-BioNTech Vaccines for Children 6 Months and Older
The FDA grants authorization for the use of Moderna and Pfizer-BioNTech COVID-19 vaccines in children aged 6 months and older, citing favorable risk-benefit profiles and the urgency of vaccinating pediatric populations.
January 2023
Unexplained Hepatitis in Children: Adenoviruses Under Investigation
Adenoviruses emerge as a primary focus of research into unexplained hepatitis in children, highlighting the need for comprehensive diagnostic evaluations and targeted therapeutic interventions in pediatric liver disease.
January 2023
Polycystic Ovary Syndrome Associated with Multimorbidity and Medication Use in Women Regardless of BMI
Women with polycystic ovary syndrome (PCOS) experience multimorbidity and medication use regardless of body mass index (BMI) in late childbearing age, highlighting the systemic nature of PCOS-related health implications.
January 2023
Pulmonary Sarcoidosis: Understanding a Multisystem Inflammatory Disease
Pulmonary sarcoidosis is a multisystem inflammatory granulomatous disease primarily affecting young adults, necessitating comprehensive evaluation and management approaches to address its varied clinical manifestations and systemic implications.
January 2023
Prolonged Hepatic Manifestations Observed in Pediatric COVID-19 Patients
Five pediatric patients who recovered from COVID-19 subsequently developed liver injury, highlighting the prolonged hepatic manifestations of the disease in children and emphasizing the need for continued monitoring and management.
January 2023
Gun-Related Deaths Reach New Peak Among Children and Adolescents in the United States
Gun-related deaths among children and adolescents in the United States reach a new peak in 2020, underscoring the urgent need for effective firearm safety measures and violence prevention strategies to protect vulnerable populations.
January 2023
Diabetic Retinopathy Progression Examined in Adolescents and Young Adults with Type 2 Diabetes
Development and progression of diabetic retinopathy in adolescents and young adults with type 2 diabetes are investigated, providing insights into the ocular complications of early-onset diabetes and informing screening and management guidelines.
January 2023
CDC Recommends Booster Shots for Children Ages 5 to 11, along with Two Boosters for Adults over 50 and Immunocompromised Individuals
The CDC recommends booster shots for children ages 5 to 11, administered five months after their initial COVID-19 vaccination series, in addition to two booster doses for adults over 50 and immunocompromised individuals, aiming to enhance vaccine-induced immunity and protect vulnerable populations against severe COVID-19 outcomes.
January 2023
Childhood Cardiovascular Risk Factors and Their Impact on Adult CV Events
Body mass index, systolic blood pressure, total cholesterol level, triglyceride level, and youth smoking are significant childhood cardiovascular risk factors that impact the risk of cardiovascular events in adulthood, underscoring the importance of early intervention and preventive measures.
December 2022
